Will Cannabis Seeds Be Banned?< > 자유게시판

Will Cannabis Genetics Be Banned?

A redefinition of hemp under federal law, set to take place Nov. 12, signals the end of Farm Bill safeguards for numerous hemp-derived THC products across the country: mild beverages as well as THCA flower and delta-8 THC edibles, vapes and additional products sold at gas stations and smoke shops.

But the hemp ban also generates a major complication for the legitimate cannabis sector. Seeds from cannabis varieties that generate flower with more than 0.3% THC are no longer legal to transport out of state.

Although seed purchases will likely continue in authorized states, https://nativesusa.com/ (https://nativesusa.com/) the changes threaten to close some seed banks and genetics businesses, observers note, while causing supply-chain problems for cannabis cultivators and retailers.

"If this wording goes through, we will require pop-up shops to sell seeds in each state where it's permitted," Campanella said. "Which is why we're also providing clones and tissue cultivation, because that's not covered in the bill."

When are cannabis seeds and clones prohibited to ship across state lines?

The updated regulations categorize seeds depending on the THC potential of the mother plant. Genetic substances such as seeds and clones are rendered illegal if the final product exceeds the threshold.

For the moment, seeds are still shipping under the 2018 Farm Bill's status quo. But the time is ticking for enterprises like Brothers Grimm and for cannabis cultivators who fear supply chain disruptions if out-of-state availability to genetics is banned.

Most of the cannabis industry remains mostly unaware of the approaching shutdown of the interstate genetics marketplace, said Ryan Power, co-founder of Sebastopol, California-based breeder Atlas Seed.

Without federal intervention in the way of a carve-out for seeds or an overall moratorium, numerous seed suppliers will simply be shuttered by November, he added.

"We are functioning legally currently, but if that shifts, it will disrupt the legal licensed sector in every state," said Power, whose clientele includes seed banks as well as licensed business cultivators.

"Customers are going to forfeit choice, and it will be a major shutdown for many people."

What are cannabis seed banks doing to stay legal after the federal hemp ban?

Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which strengthened cannabis supervision in that state while also limiting hemp-derived THC products to licensed cannabis retailers.

Formerly a seed supplier, Silberhaze is currently focused on the marketing, preservation and IP safeguarding of premium plant genetics.

That's because seed businesses hoping to remain compliant in this new environment must have airtight documentation, he said.

"You have to prove where this stuff comes from, so it's very important to have documentation, even to the point where you have cultivator names," Silber said.

"Smaller businesses will have to work with improved records and a stronger chain of custody," he added. "We need that documentation too, because we don't want to be working with questionable sources."

To prevent seizures and additional legal fallout, seed entrepreneurs must "get their ducks in a row" before the new regulations take effect, Silber said.

"Review all your materials immediately, and classify what you can," Silber said. "Take stock, document your lineage, preserve breeder records, and arrange any cannabinoid or terpene information you already have. If regulations change, you'll be in a much better position to understand what may be impacted and make informed decisions."

Does federal marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration registration may be required for businesses engaged in research.

But for now, seed companies can't enroll with the DEA like state-licensed medical cannabis operators can. Such a pathway is not available to seed banks, nurseries or genetics businesses, said Jim Ickes, a lawyer and partner with Frantz Ward's cannabis law group in Cleveland.

"Seed-related activity may be occurring inside larger state-licensed therapeutic marijuana operations, as some states permit dispensaries or registered medical operators to offer seeds, clones or personal growing materials," he said.

"But that is distinct from the DEA creating a freestanding seed supplier registration category."

Some genetics operators are already changing business practices to conform with the new law. According to Ickes, they must address questions including:

• Which of our varieties produce plants above 0.3% total THC?
• Which seeds remain as hemp after Nov. 12, 2026, and which don't?
• What does our inventory look like once we organize it against the viable-seed exclusion?

Ickes also recognizes confusion from customers who believed federal rescheduling of therapeutic marijuana would clarify their situation with financial institutions. However, the recent regulatory language has shifted those conversations past the basics of classification, he said.

"Banks ask whether this specific revenue source is legal, whether it ties to state-licensed activity, or whether there's interstate-commerce risk," said Ickes.

"After November, a seed supplier selling drug-type genetics can't answer the initial question with the hemp definition. It has to point to a lawful state cannabis channel instead. Seed banks dealing in authentic industrial-hemp seed keep the simpler story."

What's the outlook of cannabis genetics?

Campanella is a member of a new coalition of other breeders, farmers and researchers that's saying seeds are better defined as farm inputs than controlled substances. To that end, seeds should be managed by the U.S. Department of Agriculture, allowing the DEA to concentrate its enforcement efforts elsewhere.

"How do you regulate something based on what it could become later?" said Campanella. "Our choice is to have that wording removed, or get seeds regulated by the USDA as a hemp product."

But in the interim, Campanella is restructuring Brothers Grimm to operate outside the scope of shifting federal oversight. The company plans to keep its Colorado seed facility while positioning its Oklahoma tissue cultivation facility as a hedge against government prohibition of cannabis seeds.

As she noted: "If things develop in a way where we can't concentrate on interstate transport, we'll have additional resources to meet people's needs without putting ourselves in trouble."